C

Celltrion Pharm Inc
KOSDAQ:068760

Watchlist Manager
Celltrion Pharm Inc
KOSDAQ:068760
Watchlist
Price: 52 600 KRW 0.19% Market Closed
Market Cap: 2.2T KRW
Have any thoughts about
Celltrion Pharm Inc?
Write Note

Intrinsic Value

The intrinsic value of one Celltrion Pharm Inc stock under the Base Case scenario is 17 592.39 KRW. Compared to the current market price of 52 600 KRW, Celltrion Pharm Inc is Overvalued by 67%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
17 592.39 KRW
Overvaluation 67%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation Backtest
Celltrion Pharm Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Celltrion Pharm Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Celltrion Pharm Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Celltrion Pharm Inc

Provide an overview of the primary business activities
of Celltrion Pharm Inc.

What unique competitive advantages
does Celltrion Pharm Inc hold over its rivals?

What risks and challenges
does Celltrion Pharm Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Celltrion Pharm Inc.

Provide P/S
for Celltrion Pharm Inc.

Provide P/E
for Celltrion Pharm Inc.

Provide P/OCF
for Celltrion Pharm Inc.

Provide P/FCFE
for Celltrion Pharm Inc.

Provide P/B
for Celltrion Pharm Inc.

Provide EV/S
for Celltrion Pharm Inc.

Provide EV/GP
for Celltrion Pharm Inc.

Provide EV/EBITDA
for Celltrion Pharm Inc.

Provide EV/EBIT
for Celltrion Pharm Inc.

Provide EV/OCF
for Celltrion Pharm Inc.

Provide EV/FCFF
for Celltrion Pharm Inc.

Provide EV/IC
for Celltrion Pharm Inc.

Show me price targets
for Celltrion Pharm Inc made by professional analysts.

What are the Revenue projections
for Celltrion Pharm Inc?

How accurate were the past Revenue estimates
for Celltrion Pharm Inc?

What are the Net Income projections
for Celltrion Pharm Inc?

How accurate were the past Net Income estimates
for Celltrion Pharm Inc?

What are the EPS projections
for Celltrion Pharm Inc?

How accurate were the past EPS estimates
for Celltrion Pharm Inc?

What are the EBIT projections
for Celltrion Pharm Inc?

How accurate were the past EBIT estimates
for Celltrion Pharm Inc?

Compare the revenue forecasts
for Celltrion Pharm Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Celltrion Pharm Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Celltrion Pharm Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Celltrion Pharm Inc compared to its peers.

Compare the P/E ratios
of Celltrion Pharm Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Celltrion Pharm Inc with its peers.

Analyze the financial leverage
of Celltrion Pharm Inc compared to its main competitors.

Show all profitability ratios
for Celltrion Pharm Inc.

Provide ROE
for Celltrion Pharm Inc.

Provide ROA
for Celltrion Pharm Inc.

Provide ROIC
for Celltrion Pharm Inc.

Provide ROCE
for Celltrion Pharm Inc.

Provide Gross Margin
for Celltrion Pharm Inc.

Provide Operating Margin
for Celltrion Pharm Inc.

Provide Net Margin
for Celltrion Pharm Inc.

Provide FCF Margin
for Celltrion Pharm Inc.

Show all solvency ratios
for Celltrion Pharm Inc.

Provide D/E Ratio
for Celltrion Pharm Inc.

Provide D/A Ratio
for Celltrion Pharm Inc.

Provide Interest Coverage Ratio
for Celltrion Pharm Inc.

Provide Altman Z-Score Ratio
for Celltrion Pharm Inc.

Provide Quick Ratio
for Celltrion Pharm Inc.

Provide Current Ratio
for Celltrion Pharm Inc.

Provide Cash Ratio
for Celltrion Pharm Inc.

What is the historical Revenue growth
over the last 5 years for Celltrion Pharm Inc?

What is the historical Net Income growth
over the last 5 years for Celltrion Pharm Inc?

What is the current Free Cash Flow
of Celltrion Pharm Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Celltrion Pharm Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Celltrion Pharm Inc

Current Assets 375.8B
Cash & Short-Term Investments 43.1B
Receivables 198B
Other Current Assets 134.7B
Non-Current Assets 276.8B
Long-Term Investments 230.5m
PP&E 223.9B
Intangibles 39B
Other Non-Current Assets 13.6B
Current Liabilities 237.3B
Accounts Payable 47.4B
Accrued Liabilities 313m
Short-Term Debt 150.5B
Other Current Liabilities 39.1B
Non-Current Liabilities 25.3B
Long-Term Debt 15.6B
Other Non-Current Liabilities 9.6B
Efficiency

Earnings Waterfall
Celltrion Pharm Inc

Revenue
437.4B KRW
Cost of Revenue
-323.1B KRW
Gross Profit
114.3B KRW
Operating Expenses
-85B KRW
Operating Income
29.3B KRW
Other Expenses
-12.8B KRW
Net Income
16.5B KRW

Free Cash Flow Analysis
Celltrion Pharm Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Celltrion Pharm Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
50/100
Profitability
Score

Celltrion Pharm Inc's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Celltrion Pharm Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
56/100
Solvency
Score

Celltrion Pharm Inc's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Celltrion Pharm Inc

There are no price targets for Celltrion Pharm Inc.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Celltrion Pharm Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Celltrion Pharm Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Celltrion Pharm Inc

Country

Korea

Industry

Pharmaceuticals

Market Cap

2.2T KRW

Dividend Yield

0%

Description

Celltrion Pharm, Inc. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Cheongju, Chungcheongbuk-Do and currently employs 841 full-time employees. The company went IPO on 2006-02-03. The Company’s products include hepatotonics, analgesics, antipyretics, anti-inflammatory drugs, antihistamines, respiratory apparatus drugs, circularly system drugs, digestives and stomachic drugs, hormone disease drugs, antibiotics, nutrients, tonics, and other drugs. The company also provides ethical drugs and over-the-counter (OTC) drugs. The firm distributes its products in domestic market and overseas markets such as Philippines, Kazakhstan, Cambodia and other Southeast Asia countries.

Contact

CHUNGCHEONGBUK-DO
Cheongju
82, 2sandan-ro, Ochang-eup, Cheongwon-gu
+82437177000
www.celltrionph.com

IPO

2006-02-03 00:00:00

Employees

841

Officers

President
Sang-Suk Kim
CEO & Internal Director
Jung-su Seo

See Also

Discover More
What is the Intrinsic Value of one Celltrion Pharm Inc stock?

The intrinsic value of one Celltrion Pharm Inc stock under the Base Case scenario is 17 592.39 KRW.

Is Celltrion Pharm Inc stock undervalued or overvalued?

Compared to the current market price of 52 600 KRW, Celltrion Pharm Inc is Overvalued by 67%.

Back to Top